SUBLIME THERAPEUTICS
Sublime Therapeutics is an early stage, privately held biotechnology company based in the San Francisco Bay Area focused on developing proprietary anti-gastrin technology to address significant unmet medical needs in gastrointestinal, pancreatic and neuroendocrine cancers as well as gastrointestinal premalignant conditions such as Barrett’s Esophagus.
SUBLIME THERAPEUTICS
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
2017-01-01
Address:
San Ramon, California, United States
Country:
United States
Total Employee:
1+
Status:
Active
Total Funding:
100 K USD
Similar Organizations
Cabaletta Bio
Cabaletta Bio has adapted clinically-validated and FDA-approved CAR T cell technology to target B cell-mediated autoimmune diseases.
Chimeron Bio
Chimeron Bio develops agents for personalized cancer gene therapy.
Slingshot Biosciences
Slingshot Biosciences develops next-generation synthetic cells for diagnostics and therapeutics.
Spark Therapeutics
Spark Therapeutics is focused on the development of gene therapy.
Founder
Investors List
Berkeley SkyDeck Fund
Berkeley SkyDeck Fund investment in Seed Round - Sublime Therapeutics